- Previous Close
267.00 - Open
262.00 - Bid 256.00 x --
- Ask 257.00 x --
- Day's Range
252.00 - 262.00 - 52 Week Range
252.00 - 495.00 - Volume
328,400 - Avg. Volume
146,313 - Market Cap (intraday)
12.85B - Beta (5Y Monthly) 0.33
- PE Ratio (TTM)
-- - EPS (TTM)
-47.62 - Earnings Date May 8, 2025 - May 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 29, 2021
- 1y Target Est
--
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines in Japan and internationally. The company provides OTC medicines for the treatment of loose stools, diarrhea, vomiting, food and water poisoning symptoms, and toothache; and quasi-drugs for regulation of intestinal movements, relieves stomach distention, loose stools, and constipation. It manufactures and sells infection control products. Taiko Pharmaceutical Co.,Ltd. exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
www.seirogan.co.jp--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 4574.T
View MorePerformance Overview: 4574.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4574.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4574.T
View MoreValuation Measures
Market Cap
12.85B
Enterprise Value
10.30B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.06
Price/Book (mrq)
1.66
Enterprise Value/Revenue
1.67
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
14.27%
Return on Assets (ttm)
2.99%
Return on Equity (ttm)
12.22%
Revenue (ttm)
6.29B
Net Income Avi to Common (ttm)
898M
Diluted EPS (ttm)
-47.62
Balance Sheet and Cash Flow
Total Cash (mrq)
4.53B
Total Debt/Equity (mrq)
25.46%
Levered Free Cash Flow (ttm)
-330.75M